HORSHAM, United Kingdom--(BUSINESS WIRE)--Envision Pharma Group ("Envision"), an innovative, technology-enabled scientific communications company focused on the biopharma and medical device industries, announced today that it has acquired Alligent Biopharm Consulting LLC ("Alligent"). Alligent is a leading Medical Affairs agency that develops and delivers strategically-focused, integrated and aligned medical communications solutions to the biopharma industry. The deal was supported by the Halifax Group, a leading private equity firm which invests in health and biopharma services businesses, partnering with the Envision management team to provide the equity investment to facilitate the acquisition. Additional terms of the transaction were not disclosed.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
